Efficacy and Safety of LetibotulinumtoxinA Injection for Trapezius Hypertrophy: A Prospective, Randomized, Double-Blind Trial
Aesthetic Plastic Surgery · 2026-07 · 50 (13) · 5260-5268
DOI: 10.1007/s00266-026-05802-6 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Plastic Surgery, online erschienen am 02.04.2026. Verfasst von Tae Hyung Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Olympic-ro 43-gil, Songpa-gu, Seoul, …. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Superficial Back Muscles, Neuromuscular Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Hugel.
Abstract (Originalsprache)
BACKGROUND: Trapezius hypertrophy is a significant aesthetic concern among women. Botulinum toxin has emerged as a potential treatment option for this condition. In this study, we conducted a prospective, randomized, double-blind trial to evaluate the effectiveness and safety of letibotulinumtoxinA specifically for women. METHODS: We conducted a prospective study between July 2022 and June 2023, recruiting 20 patients seeking treatment for trapezius hypertrophy. LetibotulinumtoxinA (Botulax®) was used as the neurotoxin. The patients were randomized into group A (n = 10, 40 units) and group B (n = 10, 80 units). Each group received different doses of toxin at 10 injection points along the trapezius muscle. RESULTS: We analyzed the contour changes in two groups and calculated the average area before and after treatment. After 12 weeks post-treatment, both groups demonstrated a decrease in the trapezius area with statistically significant differences (p = 0.011, p = 0.005). The median satisfactory score was 4, indicating a moderate level of satisfaction in both groups. No statistically significant differences or complications were observed between the groups. CONCLUSION: LetibotulinumtoxinA for trapezius hypertrophy demonstrated efficacy with no differences between two experimental groups. Aesthetic concerns were addressed, enhancing shoulder and neck appearance with a high degree of satisfaction. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Olympic-ro 43-gil, Songpa-gu, Seoul, South Korea.
- Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine, Olympic-ro 43-gil, Songpa-gu, Seoul, South Korea. wsjeong@amc.seoul.kr.
Förderung
- Hugel
Zitieren
APA
Kim, T. H., Kang, H. I., Lee, S. J., & Jeong, W. S. (2026). Efficacy and Safety of LetibotulinumtoxinA Injection for Trapezius Hypertrophy: A Prospective, Randomized, Double-Blind Trial. Aesthetic Plastic Surgery, 50(13), 5260-5268. https://doi.org/10.1007/s00266-026-05802-6
Vancouver
Kim TH, Kang HI, Lee SJ, Jeong WS. Efficacy and Safety of LetibotulinumtoxinA Injection for Trapezius Hypertrophy: A Prospective, Randomized, Double-Blind Trial. Aesthetic Plastic Surgery. 2026;50(13):5260-5268. doi:10.1007/s00266-026-05802-6
BibTeX
@article{Kim2026,
author = {Kim, Tae Hyung and Kang, Hyun Il and Lee, Seok Joon and Jeong, Woo Shik},
title = {Efficacy and Safety of LetibotulinumtoxinA Injection for Trapezius Hypertrophy: A Prospective, Randomized, Double-Blind Trial},
journal = {Aesthetic Plastic Surgery},
year = {2026},
volume = {50},
number = {13},
pages = {5260--5268},
doi = {10.1007/s00266-026-05802-6}
}
EUVIMED